Back to Search
Start Over
Sapien S3 transcatheter pulmonary valve replacement: an excellent option but not a panacea.
- Source :
- European Heart Journal; 1/14/2024, Vol. 45 Issue 3, p211-213, 3p
- Publication Year :
- 2024
-
Abstract
- The article discusses the results of a large European registry on the Sapien S3 transcatheter pulmonary valve replacement (TPVR). The registry data shows that the Sapien S3 valve performs well in the short- and intermediate-term, especially when treating dysfunctional conduits or bioprosthetic valves. However, there are challenges when using the Sapien S3 in patients with native right ventricular outflow tract (RVOT) anatomy, with a 12% complication rate related to pre-stent migration/embolization and valve malposition. The article also highlights concerns about infective endocarditis rates and leaflet thrombosis in TPVR patients. Overall, while the Sapien S3 is a promising option, it is not a panacea and there are still important considerations and risks to be aware of. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 0195668X
- Volume :
- 45
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- European Heart Journal
- Publication Type :
- Academic Journal
- Accession number :
- 174783610
- Full Text :
- https://doi.org/10.1093/eurheartj/ehad769